ReviewJournal of nutrition and metabolism2026
Nutrition in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Review in Journal of nutrition and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nutrition in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Journal of nutrition and metabolism · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lifestyle change, including weight loss in children with overweight and obesity, through intensive health behavior and lifestyle treatment (IHBLT) is one of the main pillars in the management of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD). Approximately 10% of school-aged children in the United States-and an even higher percentage of children with obesity-are affected by MASLD. The stigma, combined with peer and society pressure to maintain a "healthy" weight, as it pertains to MASLD, has led a percentage of affected children to adapt restrictive patterns of eating that have culminated in malnutrition, nutrient deficiencies, disordered eating, anxiety and mood, and eating disorders. Prompt recognition through screening and targeted interventions is needed to address this crisis. Our paper offers a concise review and approach to the nutrition evaluation and assessment of malnutrition and nutrition deficiencies in children with pediatric obesity and MASLD and addresses interventions considered to mitigate this health outcome. We reviewed the literature pertaining to pediatric MASLD and malnutrition, nutrient deficiencies, eating behaviors, eating disorders, disordered eating, and food insecurity in the pediatric population. We focused on the evaluation, assessment, and management of malnutrition and nutrition and behavioral interventions recommended in pediatric MASLD. Overall, IHBLT alone has not been sufficient to curb the pediatric obesity and MASLD epidemic, and there has been a growing interest in specific pediatric MASLD pharmacotherapies and their related nutritional and behavioral side effects. Ultimately, assessing and addressing nutrient deficiencies, mood disturbances, and disordered eating behaviors is critical to mitigating the long-term consequences of this disease, while improving food access and distribution can further optimize metabolic health outcomes through high-quality nutrition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.